Lincoln Pharma ... the next mid-cap pharma in the making ...?

I am not concerned about the private lending if they are doing with a small quantum
Look at the rise of Loans and Advances given since 2021 from 21 crores to 142 crores
Right now these loans and advances constitute 20% of their net worth.

9 Likes

In conversation with Mahendra Patel, Managing Director…

They are still sticking with their growth guidance to reach 750 crores by the end of FY26
I don’t know how will they pull this out considering their 1st quarter performance was flat

Disc: Invested

3 Likes

I have been tracking this company for the last few years. Surprised to see this not falling much in such a volatile market, and in fact had a good run-up with decent volumes.

Does anyone know what’s cooking here?

Pharma stocks are usually safe bet during turbulent times. This is the only reason. Nothing else

1 Like